These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29924777)

  • 1. [Vascular stents: Approaches used to increase their clinical efficacy].
    Kuznetsov KA; Khar'kova MV; Karpenko AA; Laktionov PP
    Angiol Sosud Khir; 2018; 24(2):69-79. PubMed ID: 29924777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Devices and techniques for endovascular surgery: catheters, stents, coated stents, and stented grafts.
    Pukin L
    Mt Sinai J Med; 2003 Nov; 70(6):386-92. PubMed ID: 14647873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioscopic findings after drug-eluting stent implantation.
    Takano M; Mizuno K
    Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
    Mehilli J; Kastrati A; Wessely R; Dibra A; Hausleiter J; Jaschke B; Dirschinger J; Schömig A;
    Circulation; 2006 Jan; 113(2):273-9. PubMed ID: 16391155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.
    Pérez de Prado A; Pérez Martínez C; Cuellas Ramón C; Regueiro Purriños M; López Benito M; Gonzalo Orden JM; Rodríguez Altónaga JA; Estévez Loureiro R; Benito González T; Viñuela Baragaño D; Molina Crisol M; Amorós Aguilar M; Pérez Serranos I; Vidal Parreu A; Benavides Montegordo A; Duocastella Codina L; Fernández Vázquez F
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1059-1066. PubMed ID: 28647315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents, restenosis and revascularization.
    Ramcharitar S; Gaster AL; Daemen J; Serruys P
    Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.
    Anaya-Ayala JE; Smolock CJ; Colvard BD; Naoum JJ; Bismuth J; Lumsden AB; Davies MG; Peden EK
    J Vasc Surg; 2011 Sep; 54(3):754-9. PubMed ID: 21664095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular pathology of drug-eluting stents.
    Nakazawa G; Finn AV; Virmani R
    Herz; 2007 Jun; 32(4):274-80. PubMed ID: 17607533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
    J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
    Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
    J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the outcomes of stent placement and the properties of arteriovenous graft outflow vein stenotic lesions.
    Yamamoto Y; Nakamura J; Nakayama Y; Hino H; Kobayashi H; Sugiura T
    J Vasc Access; 2012; 13(4):426-31. PubMed ID: 22505281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.